⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AARD News
Aardvark Therapeutics, Inc. Common Stock
Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors – AARD
globenewswire.com
AARD
Faruqi & Faruqi, LLP Urges Aardvark Therapeutics (NASDAQ: AARD) Investors to Seek Counsel Before October 13, 2026 Lead Plaintiff Deadline in the Securities Class Action
accessnewswire.com
AARD
Law Offices of Frank R. Cruz Encourages Aardvark Therapeutics, Inc. (AARD) Shareholders to Inquire About Securities Fraud Class Action
businesswire.com
AARD
Aardvark Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AARD
businesswire.com
AARD
Pomerantz LLP Announces The Filing of a Class Action Litigation Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
Levi & Korsinsky Notifies Aardvark Therapeutics, Inc. (AARD) Shareholders of Class Action Lawsuit and October 13, 2026 Deadline
accessnewswire.com
AARD
Aardvark Therapeutics, Inc. (AARD) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before October 13, 2026
accessnewswire.com
AARD
AARD ALERT: Securities Fraud Class Action Launched Against Aardvark Therapeutics, Inc. - October 13, 2026 Deadline
accessnewswire.com
AARD
AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
businesswire.com
AARD
LAWSUIT ALERT: Investors who lost over $100,000 with Aardvark Therapeutics, Inc. (NASDAQ: AARD) between February 2025 and May 2026, should contact the Shareholders Foundation
prnewswire.com
AARD